Skip to main content
Clinical Trials/JPRN-UMIN000044521
JPRN-UMIN000044521
Not Yet Recruiting
N/A

Clinical evaluation on the pain-reducing effect of Aconinsan for burning mouth syndrome - Clinical evaluation on the pain-reducing effect of Aconinsan

Saga University0 sites64 target enrollmentJuly 5, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Burning mouth syndrome
Sponsor
Saga University
Enrollment
64
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2021
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patient suffer from Angle\-closure Glaucoma 2\)Patient have medical history of hypersensivity to prescription drug 3\)Patient have medical history of cardiovascular disease and cerebrovascular disorder 4\)Patient suffer from prostate disease 5\)Patient who administered MAOI 6\)Patient suffer from hyperthyroidism 7\)Patient suffer from convulsive disorder 8\)Patient suffer from manic depression 9\)Patients with organic brain disorders or predisposition to schizophrenia 10\)Patients who have or have had suicidal thoughts or suicide attempts 11\)Patients taking other antidepressants, anti\-epileptic drugs, anti\-anxiety drugs, etc. 12\)Patient who is judged inappropriate by doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials